Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04245696

Bipolar RF Microneedling for Improved Laxity and Lift of the Submental and Neck Tissue and Effect on Elastin

Clinical Assessment of Bipolar Radiofrequency Microneedling for Improved Laxity and Lift of the Submental and Neck Tissue

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Candela Corporation · Industry
Sex
All
Age
21 Years – 70 Years
Healthy volunteers
Accepted

Summary

This study is being conducted to evaluate the safety and efficacy of bipolar fractional radiofrequency treatment via use of the Profound System to achieve lift in lax submental (beneath the chin) and neck tissue

Detailed description

A multi-center, blinded, non-randomized, non-controlled study Up to 60 eligible participants will be enrolled at up to three (3) sites. Participants will receive one (1) treatment in the submental/neck area. Participants will complete follow-up visits for clinical evaluation at Day 14, 1 Month, 3 Month, and 6 Months after the study treatment. Standard photography will be obtained at Screening to the 6 Month follow-up, and 3D photography will be obtained at Screening, Month 3, and Month 6 visit.

Conditions

Interventions

TypeNameDescription
DEVICEDermal Handpiece / SubQ HandpieceBipolar radiofrequency (RF) travels from the RF generator, through the electrodes and into the dermal layers beneath the surface of the skin. The microneedles of the Dermal and SubQ cartridges coupled with thermal heat will stimulate neocollagenesis and neoelastosis, aiding in the reduction of submental laxity.

Timeline

Start date
2020-03-09
Primary completion
2021-08-05
Completion
2021-08-05
First posted
2020-01-29
Last updated
2021-08-06

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04245696. Inclusion in this directory is not an endorsement.